Indiana University Review and Interpretation of the ASCO Meeting 2024

This program will provide the participants with the latest information available as presented at the 2024 American Society of Clinical Oncology (ASCO) meeting. Oncology/Hematology faculty members from the Indiana University School of Medicine will provide participants with analysis of the more clinically applicable presentations at this year’s ASCO meeting.

Objectives

1. Recall and describe the newest developments in the treatment of breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, head/neck cancer, melanoma, hematological mallignancies.
2. Integrate multimodality treatment strategies, including radiation therapy, chemotherapy, immunotherapy, and targeted therapy, into the management of patients with cancer.
3. Based on the most up-to-date treatments described in the learning sessions, apply new knowledge and strategies about therapies of solid tumors and hematological malignancies into their clinical practice.